1. Home
  2. Labeler Index
  3. Asclemed Usa, Inc.
  4. 76420-766
  5. NDC Package Code: 76420-766-01 Doubledex Kit

NDC Package 76420-766-01 Doubledex Kit

Dexamethasone Sodium Phosphate,Povidine Iodine Kit Intramuscular; Intravenous; Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
76420-766-01
Package Description:
1 KIT in 1 CARTON * .9 mL in 1 PACKET (67777-419-02) * 5 mL in 1 POUCH * 25 VIAL in 1 TRAY (63323-506-01) / 1 mL in 1 VIAL
Product Code:
76420-766
Proprietary Name:
Doubledex Kit
Non-Proprietary Name:
Dexamethasone Sodium Phosphate, Povidine Iodine
Usage Information:
By intravenous or intramuscular injection when oral therapy is not feasible:1. Endocrine Disorders     Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids     where applicable; in infancy, mineralocorticoid supplementation is of particular importance).     Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs     are used).     Preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful.     Shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected.     Congenital adrenal hyperplasia      Nonsuppurative thyroiditis     Hypercalcemia associated with cancer2. Rheumatic Disorders     As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:     Post-traumatic osteoarthritis     Synovitis of osteoarthritis     Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy).     Acute and subacute bursitis     Epicondylitis     Acute nonspecific tenosynovitis     Acute gouty arthritis     Psoriatic arthritis     Ankylosing spondylitis3. Collagen Diseases     During an exacerbation or as maintenance therapy in selected cases of:     Systemic lupus erythematosus     Acute rheumatic carditis4. Dermatologic Diseases     Pemphigus     Severe erythema multiforme (Stevens-Johnson syndrome)     Exfoliative dermatitis     Bullous dermatitis herpetiformis     Severe seborrheic dermatitis     Severe psoriasis     Mycosis fungoides 5. Allergic States     Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in:     Bronchial asthma     Contact dermatitis     Atopic dermatitis     Serum sickness     Seasonal or perennial allergic rhinitis     Drug hypersensitivity reactions     Urticarial transfusion reactions     Acute noninfectious laryngeal edema (epinephrine is the drug of first choice).6. Ophthalmic Diseases     Severe acute and chronic allergic and inflammatory processes involving the eye, such as:     Herpes zoster ophthalmicus     Iritis, iridocyclitis     Chorioretinitis     Diffuse posterior uveitis and choroiditis     Optic neuritis     Sympathetic ophthalmia     Anterior segment inflammation     Allergic conjunctivitis     Keratitis     Allergic corneal marginal ulcers 7. Gastrointestinal Diseases     To tide the patient over a critical period of the disease in:     Ulcerative colitis (systemic therapy)     Regional enteritis (systemic therapy)8. Respiratory Diseases     Symptomatic sarcoidosis     Berylliosis     Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy.     Loeffler’s syndrome not manageable by other means.     Aspiration pneumonitis 9. Hematologic Disorders     Acquired (autoimmune) hemolytic anemia.     Idiopathic thrombocytopenic purpura in adults     (IV only; IM administration is contraindicated).     Secondary thrombocytopenia in adults     Erythroblastopenia (RBC anemia)     Congenital (erythroid) hypoplastic anemia10. Neoplastic Diseases     For palliative management of:     Leukemias and lymphomas in adults     Acute leukemia of childhood11. Edematous States     To induce diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.12. Miscellaneous     Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy.     Trichinosis with neurologic or myocardial involvement.13. Diagnostic testing of adrenocortical hyperfunction.14. Cerebral Edema associated with primary or metastatic brain tumor, craniotomy, or head injury.  Use in cerebral edema is not a substitute for careful neurosurgical evaluation     and definitive management such as neurosurgery or other specific therapy.  
11-Digit NDC Billing Format:
76420076601
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
  • RxCUI: 1812079 - dexAMETHasone sodium phosphate 10 MG in 1 ML Injection
  • RxCUI: 1812079 - 1 ML dexamethasone phosphate 10 MG/ML Injection
  • RxCUI: 1812079 - dexamethasone phosphate 10 MG (as dexamethasone sodium phosphate 11 MG) per 1 ML Injection
  • RxCUI: 797544 - isopropyl alcohol 70 % Medicated Pad
  • RxCUI: 797544 - isopropyl alcohol 0.7 ML/ML Medicated Pad
Product Type:
Human Prescription Drug
Labeler Name:
Asclemed Usa, Inc.
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Sample Package:
No
Marketing Category:
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date:
07-25-2014
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 76420-766-01?

The NDC Packaged Code 76420-766-01 is assigned to a package of 1 kit in 1 carton * .9 ml in 1 packet (67777-419-02) * 5 ml in 1 pouch * 25 vial in 1 tray (63323-506-01) / 1 ml in 1 vial of Doubledex Kit, a human prescription drug labeled by Asclemed Usa, Inc.. The product's dosage form is kit and is administered via intramuscular; intravenous; topical form.

Is NDC 76420-766 included in the NDC Directory?

Yes, Doubledex Kit with product code 76420-766 is active and included in the NDC Directory. The product was first marketed by Asclemed Usa, Inc. on July 25, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 76420-766-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 76420-766-01?

The 11-digit format is 76420076601. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-276420-766-015-4-276420-0766-01